Pharmafile Logo
Pharmafocus logo
Advanced Search

Valeant

Showing 15 posts of 90 posts found.

Valeant logo

Valeant announces strong Q3 results, will expand US contact lens plant

October 20, 2015
Manufacturing and Production, Sales and Marketing Valeant, financial results, manufacturing, production

Valeant has announced plans to invest up to $150 million and add 200 jobs at its Bausch and Lomb plant …

News
Valeant logo

Valeant receives court writ over US drug pricing

October 15, 2015
Medical Communications, Sales and Marketing Drug pricing, Isuprel, Nitropress, US, Valeant, subpoena

Valeant Pharmaceuticals has disclosed that it has received two subpoenas in the US, demanding evidence concerning the pricing and distribution …

News
Sprout sign

Valeant confirms $1bn deal for ‘female viagra’ creator Sprout

August 20, 2015
Manufacturing and Production, Sales and Marketing Addyi, Sprout, Sprout Pharma, Sprout Pharmaceuticals, Valeant, flibanserin

Canada’s Valeant Pharmaceuticals has confirmed it will pay $1 billion to acquire Sprout Pharmaceuticals, the company behind the female libido …

News
Egyptian flag

Valeant in $800 million deal for Amoun Pharma

July 20, 2015
Sales and Marketing Amoun, Egypt, MENA, Valeant, acquisitions

Valeant is striking out in the acquisitions market yet again, having agreed an $800 million deal to buy Egypt’s largest …

News
Valeant image

Valeant looking to buy Zoetis

June 26, 2015
Sales and Marketing Actavis, Allergan, Valeant, Zoetis, brett wells

Canadian drugmaker Valeant Pharmaceuticals has made a move to acquire animal health company Zoetis. This is according to the Wall …

News
Allergan logo

Actavis changes its name to Allergan

June 16, 2015
Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Valeant

Actavis has now officially changed its name to Allergan following the Ireland-based company’s recent acquisition of the botox maker. This …

News
valeant_pharma

Actavis and Valeant see FDA approval for IBS drugs

May 28, 2015
Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells

Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …

News
endo image

Endo lands a big fish with $8 billion Par Pharma deal

May 19, 2015
Sales and Marketing Endo, Valeant, par pharma

Endo is switching strategies from attempting to buy specialist pharma firms, to generics, having announced a huge $8 billion deal …

News

Hundreds of jobs threatened after big pharma deals close

April 7, 2015
Medical Communications, Research and Development, Sales and Marketing Deals, GSK, Jobs, Novartis, US, Valeant, job losses, redundancy, salix

Fresh from deals worth a combined $34 billion, GSK and Salix Pharmaceuticals have announced company restructures that have placed more …

News
Valeant image

Valeant sprints ahead of Endo to secure Salix

March 18, 2015
Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix

Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …

News
Salix image

Endo attempts to outbid Valeant for Salix Pharma

March 12, 2015
Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix

Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …

News
Valeant image

Valeant to buy Salix in $14.5 billion move

February 23, 2015
Sales and Marketing Deals, Heptares, Valeant, mergers, salix, sosei

Valeant has agreed a deal to acquire US-based speciality manufacturer of gastrointestinal drugs Salix in a move worth around $14.5 …

News
Valeant pharma

Valeant recalls drug used on hospitalised infants

January 6, 2015
Manufacturing and Production, Sales and Marketing Actavis, Allergan, FDA, Valeant, manufacturing, recall, ribavirin, virazole

North American drug firm Valeant Pharmaceuticals has issued a voluntary nationwide recall of Virazole due to microbial contamination. Virazole (ribavirin …

News
allergan image

Actavis buys Allergan for $66 billion

November 18, 2014
Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Canada, Valeant, merger

The stately dance between Actavis and Allergan has culminated in the former buying the Botox manufacturer in a $66 billion …

News
Allergan image

Allergan eyeing Actavis buyout

November 13, 2014
Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Botox, Valeant, acquisition, buyout, merger

Allergan is attempting to block a recent Valeant hostile takeover bid by seeking the rumoured alternative merger deal with Actavis, …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025